New requirements for medicine registration in the EU will improve global data exchange between pharmaceutical companies and regulators
June 14, 2021
March 30, 2020
Inpharmatis Team COVID-19 Update
| We are taking all necessary measures to reduce the spread of the COVID-19 virus. The safety of our clients, partners and employees is our priority. Therefore, we have canceled all personal meetings and planned training courses. Due to the COVID-19 expansion geographically, also most GMP inspections have been suspended, traveling limited and a lot of companies begin teleworking. |
| Our team is continuing to work remotely, and available in normal working hours to support you during this difficult time as best as possible. |
| We value and respect our client’s business and are committed to delivering results by knowledgeable focus, meeting deadlines and professional project management despite the global COVID-19 situation. |
Our team of highly experienced experts is highly committed to supporting you during this difficult time as best as possible by continuing to provide full pharmaceutical product life-cycle management over the whole of EU & CIS in pharmacovigilance, regulatory affairs, medical writing, market access services and a range of specific software to the pharmaceutical industry. |
| To maintain our client’s business continuity, we are delighted also to propose comprehensive and detailed GMP audit reports of active pharmaceutical ingredients (API) manufacturers performed by Inpharmatis. |
Schedule with us virtual meetings and find out how can we help you. Please email your request to info@inpharmatis.com or call us +371 6721 0500. |
| Our CEO Dr. P.Dombure is reminding and repeatedly advising all employees, clients, and partners to practice a social distancing and take all proper hygiene steps thus reducing the risk of infection or spreading the infection to others. |
| Stay strong and healthy! |
| Kind regards, |
| Inpharmatis team |
Новые требования к подаче сведений при регистрации лекарственных средств в Евросоюзе улучшат глобальный обмен данными между фармкомпаниями и регуляторами
June 10, 2021
Inpharmatis принял участие в работе ПМЭФ-2021
June 04, 2021
Ольга Звонарева возглавит в Inpharmatis направление Regulatory Affairs в России и странах СНГ
May 31, 2021
Inpharmatis appoints new RA Director in Russia & CIS
May 31, 2021
Приведение досье в соответствие с правилами ЕАЭС
May 27, 2021
Bringing the dossier in accordance with the rules of the EAEU
May 27, 2021
Inpharmatis и «АКАДЕМФАРМ» обсудили в Минске перспективы сотрудничества
May 21, 2021
Inpharmatis and “ACADEMPHARM” discussed in Minsk cooperation opportunities
May 21, 2021
Participation in IPhEB Russia 2021
April 19, 2021